Literature DB >> 6272629

In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.

A Eley, D Greenwood.   

Abstract

Minimum inhibitory concentrations of ceftizoxime for seven clinical isolates of Bacteroides fragilis were found to be markedly affected by inoculum size; the very low minimum inhibitory concentration values (less than or equal to 0.25 microgram/ml) obtained in tests with most strains were not sustained when the inoculum was raised 100-fold. Benzylpenicillin and cephalothin were also affected by inoculum size, but cefoxitin was not. Antibiotic assays showed that the strains inactivated ceftizoxime and cephalothin completely, benzylpenicillin partially, and cefoxitin not at all. Morphological investigations revealed that populations of B. fragilis responded differently to each of the four beta-lactam agents during the early stages of the encounter between B. fragilis and the antibiotic. Benzylpenicillin and cefoxitin induced spheroplast formation at lower concentrations than did ceftizoxime. Cephalothin evoked a novel morphological response that was not seen with other beta-lactam agents.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272629      PMCID: PMC181696          DOI: 10.1128/AAC.20.3.332

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  A twelve channel bacterial growth monitoring system.

Authors:  I P Mackintosh; F O'Grady; D Greenwood; B W Watson; T C Crichton; R Piper; A Ferrer
Journal:  Biomed Eng       Date:  1973-12

2.  Bacteroides fragilis and HR 756.

Authors:  R Wise
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

3.  Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.

Authors:  K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

4.  Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.

Authors:  D Greenwood; N Pearson; A Eley; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

5.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  Inactivation of cephalosporins by Bacteroides.

Authors:  F P Tally; J P O'Keefe; N M Sullivan; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

7.  Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  T Kamimura; Y Matsumoto; N Okada; Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  7 in total
  8 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.

Authors:  M V Borobio; A Pascual; M C Dominguez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

3.  Continuous opacity monitoring of the growth of bacteria under strict anaerobic conditions.

Authors:  F O'Grady; A Eley
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

4.  Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  E D Burgess; A D Blair
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  Cefoxitin inactivation by Bacteroides fragilis.

Authors:  G J Cuchural; F P Tally; N V Jacobus; P K Marsh; J W Mayhew
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

6.  Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  F Lamothe; F Auger; J M Lacroix
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 7.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

8.  Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora.

Authors:  H Lode; H Warns; B Kemmerich; H Knothe; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.